Pixyl Medical

La Tronche, France (Grenoble region)  All France companies → — Founded 2015
Imaging AI Specialist Specialty-Focused AI
Acquired (by Gleamer on March 12, 2025)

About Pixyl Medical

Pixyl Medical is a French medtech company that develops AI-powered software solutions for neuroimaging analysis, aiming to improve patient care by providing advanced tools to radiologists and clinicians. Their flagship product, Pixyl.Neuro, leverages deep learning and generative AI to automatically analyze brain MRI images. This technology is designed to rapidly detect anomalies and changes associated with neuroinflammatory and neurodegenerative disorders, such as multiple sclerosis (MS), dementia, stroke, and traumatic brain injury.

For physicians, Pixyl.Neuro offers several key benefits. It automates time-consuming tasks like lesion counting and comparison with prior exams, reducing variability in measurements and standardizing patient monitoring. The software provides quantitative reports on lesion volume, brain atrophy, and white matter hyperintensities, along with annotated MRI images, all within minutes. This clinically relevant information assists in early diagnosis, objective monitoring, and tailoring treatment plans for patients. Pixyl.Neuro has received CE-mark class IIa certification in the European Union and FDA 510(k) clearance in the US, ensuring its quality and regulatory compliance.

Focus Areas

neuroimaging artificial intelligence multiple sclerosis dementia stroke traumatic brain injury neurodegenerative diseases neuroinflammatory disorders

Business Intelligence

TechnologyAI-powered, deep learning, generative AI, cloud-native (SaaS)

What Physicians Need to Know

Neuroimaging AI Specialization
Pixyl Medical specializes in advanced AI for analyzing brain MRI images to detect anomalies and changes related to neuroinflammatory and neurodegenerative disorders, including Multiple Sclerosis, dementia, stroke, and traumatic brain injury.
Rapid Analysis
Their proprietary AI algorithms and fast computing infrastructure enable brain MRI analysis to be completed in less than five minutes, even with minimal MRI protocols.
Regulatory Clearances
Pixyl.Neuro has received FDA 510(k) clearance (Class II) in the United States and is certified as a CE-marked Class IIa medical device under European Medical Device Regulations (MDR), ensuring high quality and safety.
Disease Monitoring & Prediction
The software supports rapid detection, early diagnosis, and objective monitoring of neurological disorders. It can quantify brain region volumes, identify abnormal atrophy, and has shown the ability to predict disability progression in Multiple Sclerosis patients.
Workflow Integration
Pixyl's solutions are designed to integrate seamlessly into existing radiology workflows, providing clinically actionable information and automating time-consuming tasks like lesion counting and comparison with prior exams.
Physician Tip

For physicians, Pixyl Medical's AI-powered neuroimaging offers significant advantages. The rapid analysis (under 5 minutes) of brain MRI images allows for quicker diagnostic support and monitoring of neuroinflammatory and neurodegenerative disorders like MS and Alzheimer's. The quantitative data on lesion volume, brain atrophy, and longitudinal analysis helps in objective disease monitoring and can aid in differential diagnoses. This is particularly crucial with the advent of disease-modifying treatments, as it helps highlight disease activity and monitor evolution. The seamless integration into existing radiology workflows and the automation of tasks can reduce variability in measurements and free up radiologists' time for more complex cases, ultimately reinforcing radiology workflows and improving patient care.

Pixyl's solutions are designed for seamless integration into the radiology workflow. They have established partnerships for distribution and marketing with companies like Siemens, GE Healthcare, and Incepto. Pixyl.Neuro is available directly from Pixyl and through select distributors.

Products by Pixyl Medical

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

Pixyl Medical is a French healthtech company specializing in AI-powered MRI analysis tools for neurological disorders, particularly Multiple Sclerosis and Alzheimer's disease. Their flagship product, Pixyl.Neuro, has received FDA 510(k) clearance in the US and CE-mark class IIa certification in the EU, enabling its clinical use in over 12 countries across Europe, North America, and Africa. The software aims to improve the detection of neurological disease activity, accelerate MRI reading times, and provide objective monitoring of these conditions. While there is positive feedback from users and medical professionals regarding the product's capabilities and impact on patient care, there is limited information available on employer reviews from the requested sources, and some search results were for similarly named but unrelated companies.

Overall: Positive

Strengths

  • AI-powered software enhances detection rates of neurological disease activity by up to 28%.
  • Accelerates MRI reading time and provides rapid analysis results (within minutes).
  • Supports early diagnosis and objective monitoring of neurodegenerative and neuroinflammatory disorders.
  • Received FDA 510(k) clearance and CE-mark class IIa certification, ensuring regulatory compliance.
  • Leverages generative AI technology for robust performance in real-world practice.
  • Positive feedback from users and medical professionals, highlighting valuable support and improved patient care.

Limitations

  • Limited public employer reviews available from specified sources (G2, Glassdoor, Capterra, Reddit).
  • Some search results were for unrelated companies with similar names (e.g., Pixley Medical Clinic, Pixly, Pixxles, Picmed, Pixyls for crafting).
  • Capterra and G2 show no specific reviews for 'Pixyl Medical' or 'Pixyl.Neuro', but rather for other software or similarly named companies.

Based on reviews from: Indeed.com, Wiley Analytical Science, Medical Device Network, NeurologyLive, Applied Radiology, MEGATEK.AI, Reddit, Capterra, G2.com

Last updated: 2026-09-19

Videos

News, demos, and interviews about Pixyl Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Pixyl Medical →

View all on YouTube

Press & Coverage

Neuro. December 5, 2023
Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neuro
Pixyl announced FDA 510(k) clearance for Pixyl.Neuro, an AI software for brain MRI analysis that has shown enhanced detection rates up to 28%. The software aids in rapid detection, early diagnosis, and objective monitoring of neurological disorders, leveraging generative AI technology.
2023-12
Applied Radiology
Pixyl Nets FDA Clearance for AI-Powered Brain MR Software | Applied Radiology
Pixyl received FDA 510(k) clearance for its Pixyl.Neuro AI software, designed for brain MR analysis to support the detection, diagnosis, and monitoring of neurological disorders. The software has also obtained CE-mark class IIa certification in the European Union.
2023-11
NeurologyLive
FDA Clears AI-Powered Brain MRI Software Pixyl.Neuro | NeurologyLive
Pixyl.Neuro, an AI-powered medical technology for detecting anomalies in brain MR images for neuroinflammatory and neurodegenerative disorders, has received FDA 510(k) clearance. The software aims to improve detection and accelerate MRI reading time, having been used in over 12 countries prior to this approval.
2023-11
Medical Device Network
Pixyl obtains clearance for AI brain MRI analysis software - Medical Device Network
Pixyl has secured 510(k) clearance from the FDA for its Pixyl.Neuro AI-powered brain MRI analysis software. This software is designed to automatically analyze brain MRI images for rapid identification, diagnosis, and monitoring of neurological disorders, and has also received CE mark IIa certification in the EU.
2023-11
Health Tech World
AI-powered brain MRI software receives FDA clearance - Health Tech World
Pixyl.Neuro, a generative AI software for brain MRI analysis, has received FDA approval, making the US one of 12 countries where the platform is regulatory approved. The software automatically analyzes brain MRI images to support rapid detection, early diagnosis, and objective monitoring of neurological disorders.
2023-11
Pixyl (Press Release)
Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neurou2122
Pixyl announced FDA 510(k) clearance for Pixyl.Neurou2122, its next-generation AI software for brain MRI analysis, which has demonstrated enhanced detection rates. The software is designed to automatically analyze brain MRI images for rapid detection, early diagnosis, and objective monitoring of neurological disorders.
2023-11
PR Newswire
Brainomix announces new partnership with Pixyl to expand its offering with multiple sclerosis solution
Brainomix has partnered with Pixyl to distribute Pixyl's Neuro.MS Software as a Service (SaaS) solution, which is used in the diagnosis and treatment of patients with multiple sclerosis. This collaboration aims to expand the clinical adoption of AI-powered solutions in neurology imaging.
2022-11
ActuIA
Pixyl raises u20ac2.2 million to market its neurological pathology detection solution - ActuIA
Pixyl, a French company specializing in medical imaging, announced a u20ac2.2 million fundraising round from Elaia, Bpifrance, and Holnest. This funding aims to accelerate the marketing of its flagship software suite, Pixyl.Neuro, and facilitate expansion into the US market.
2021-04

Frequently Asked Questions

Pixyl Medical offers Pixyl.Neuro, an AI-powered software for brain MRI analysis that supports the diagnosis and monitoring of neuroinflammatory and neurodegenerative disorders. Specifically, Pixyl.Neuro.MS is designed for Multiple Sclerosis, providing quantitative reports on lesion location, volume, and evolution. Pixyl.Neuro.BV focuses on volumetric analyses for neurodegenerative pathologies, quantifying brain region volumes and identifying atrophy, which can be relevant for conditions like dementia and traumatic brain injury. While Pixyl.Neuro is geared to detect anomalies and changes in brain MR images for neuroinflammatory and neurodegenerative disorders, its application to acute stroke is not explicitly detailed as a primary product focus, though general neurological disorders are mentioned.
Pixyl Medical's Pixyl.Neuro software has received FDA 510(k) clearance in the United States and is certified as a CE-marked class IIa medical device under the new Medical Device Regulations in the European Union. This demonstrates their adherence to high-quality medical device development and AI guidelines.
The provided information does not detail the specific pricing structure or typical costs for Pixyl Medical's solutions. However, it is noted that their solutions are available directly from Pixyl and from select distributors. For specific pricing inquiries, direct contact with Pixyl Medical or their distributors would be necessary.
While the specifics of training are not detailed, Pixyl Medical emphasizes integrating AI support directly into existing infrastructure and regular clinical workflows. They also state that in case of connection problems, users should contact Pixyl customer support. This suggests direct support is available for technical issues.
Yes, Pixyl Medical has established partnerships. They have a distribution partnership with Brainomix, an AI-powered medtech solutions company, to distribute Pixyl's Neuro.MS solution in specific European markets. Pixyl also collaborates with research institutions like Inria and the Grenoble Institute of Neuroscience (GIN) for ongoing research and development. Additionally, they are a partner in the PRIMUS (Projection In Multiple Sclerosis) research project.
Pixyl Medical, founded in 2015, is an award-winning French medtech company specializing in AI-powered MRI solutions. Their Pixyl.Neuro software has been used in over 12 countries across Europe, North America, and Africa, with a four-fold increase in usage since December 2022. They have also secured significant funding rounds, indicating investor confidence. They were acquired by Gleamer.

Related Companies

CoCounsel, developed by Thomson Reuters, is a professional-grade generative AI assistant primarily designed for legal professionals, but its underlying AI technology is also applied across other professional domains like tax, accounting, audit, risk, compliance, and global trade. For physicians, understanding CoCounsel’s capabilities in the legal and compliance space is relevant, especially when dealing with legal […]

OrthoAI is a healthcare AI company that has two distinct entities. One OrthoAI, based in India, is an AI-powered surgical companion designed for orthopedic surgeons, providing evidence-based insights and decision support. It functions as a generative AI, similar to ChatGPT, specifically tailored for orthopedics, and is accessible 24/7. This platform integrates a curated database developed […]

NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]

Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]

The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]

Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.